0001819790-24-000008.txt : 20240130
0001819790-24-000008.hdr.sgml : 20240130
20240130163148
ACCESSION NUMBER: 0001819790-24-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240125
FILED AS OF DATE: 20240130
DATE AS OF CHANGE: 20240130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lin Elizabeth Yeu
CENTRAL INDEX KEY: 0001842190
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 24578622
MAIL ADDRESS:
STREET 1: 25651 ATLANTIC OCEAN DRIVE
CITY: LAKE FOREST
STATE: CA
ZIP: 92630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wk-form4_1706650295.xml
FORM 4
X0508
4
2024-01-25
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001842190
Lin Elizabeth Yeu
C/O TARSUS PHARMACEUTICALS, INC.
15440 LAGUNA CANYON ROAD, SUITE 160
IRVINE
CA
92618
1
0
0
0
0
Stock Option (right to buy)
26.25
2024-01-25
4
A
0
10000
0
A
2034-01-24
Common Stock
10000
10000
D
Option granted in connection with certain consulting services being provided by the Reporting Person. The option will vest in full on January 30, 2025, subject to the Reporting Person's continuous service through such date.
/s/ Jeffrey Farrow, Attorney-in-Fact
2024-01-30